Mirion Technologies (MIR) AI Stock Analysis

• Market Cap: $5.36B
• Dividend Yield: N/A
• Average Volume (3M): 2.88M
• Price to Earnings (P/E): 562.7
• Beta (1Y): 1.56
• Revenue Growth: 7.88%
• EPS Growth: N/A
• Country: US
• Employees: 2,800
• Sector: Industrials
• Sector Strength: 73
• Industry: Industrial - Machinery
• EPS (TTM): 0.11
• Shares Outstanding: 227,891,330
• 10 Day Avg. Volume: 2,745,743
• 30 Day Avg. Volume: 2,881,444
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.10
• Enterprise Value/Revenue: 5.40
• Enterprise Value/Gross Profit: 11.53
• Enterprise Value/Ebitda: 28.92
• 1Y Price Target: $23.00
• Price Target Upside: 0.44% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 5

• Rating: 65 Neutral
• Price Target: $24.50 ▲(6.99% Upside)

Mirion Technologies' overall score is driven by strong financial performance and positive technical indicators. However, the high P/E ratio suggests overvaluation, and challenges in certain segments pose risks. The earnings call provided a balanced view with both positive developments and ongoing challenges.

Positive Factors

Business Growth

MIR’s Nuclear & Safety business continues to have significant growth tailwinds that should be supportive of MIR’s targeted +6%-8% organic growth in the business with still meaningful margin expansion potential.

Market Position

Favorable demand drivers and MIR’s strong position within its end markets could be durable growth drivers.

Medical Division Strategy

MIR Medical strategy seems to be maturing in Medical where increased focus on integrating software with hardware, continued emphasis on independent quality assurance, and greater focus on lean/value analysis and value engineering should drive continued improvements in MIR Medical’s performance.

Nuclear Power Demand

Nuclear power generation could continue to be viewed increasingly favorably, driving solid underlying demand for MIR’s commercial nuclear business.

Negative Factors

Financial Leverage

Management noted reduced net leverage at 2.5x and indicated a 'very strong' M&A pipeline, viewing acquisition-oriented capital deployment as likely to accelerate.

Operational Challenges

An increased focus on operational execution and continuous improvement is contributing to ongoing margin expansion potential.

Mirion Technologies Business Overview & Revenue Model

Company Description

Mirion Technologies (MIR) is a leading provider of radiation detection and measurement solutions, serving a diverse range of sectors including nuclear power, medical, military, and research. The company specializes in advanced technologies for radiation safety, offering a comprehensive portfolio of products such as personal dosimeters, radiation monitoring systems, and imaging solutions. Mirion is committed to delivering innovative solutions that ensure safety and compliance in environments where radiation exposure is a concern.

How the Company Makes Money

Mirion Technologies generates revenue through multiple key streams, primarily from the sale of its radiation detection and measurement equipment, including dosimeters and monitoring systems. The company also earns income through maintenance and service contracts, providing ongoing support and calibration for its products. Additionally, Mirion benefits from strategic partnerships with key players in the nuclear and healthcare industries, allowing it to expand its market reach and enhance its product offerings. Government contracts and regulatory compliance services further contribute to its revenue, as organizations increasingly prioritize safety in radiation exposure management.

Mirion Technologies Financial Statement Overview

Summary

Mirion Technologies shows strong revenue growth and improved profitability with a positive net profit margin. The balance sheet is stable with a solid equity base, though leverage should be monitored. Cash flow management is robust, with significant free cash flow generation.

Income Statement

Mirion Technologies has shown a strong improvement in revenue, with a notable revenue growth rate from 2024 to TTM (Trailing-Twelve-Months). The gross profit margin is healthy at 51.7% for TTM. Despite past losses, the net profit margin has turned positive at 1.7% in TTM, indicating improved profitability. The EBIT and EBITDA margins are relatively low, with an EBIT margin of 5.6% and EBITDA margin of 3.8%, indicating room for improvement in operational efficiency.

Balance Sheet

The company has a solid equity base with a high equity ratio of 55.3% in TTM, reflecting financial stability. However, the debt-to-equity ratio remains moderate at 0.28, which suggests a balanced approach to leverage but still poses a potential risk if not managed carefully. The return on equity is relatively low at 1.3%, indicating limited returns on shareholders' equity.

Cash Flow

Free cash flow has shown significant growth, with a substantial increase from the previous year, highlighting strong cash generation capabilities. The operating cash flow to net income ratio is robust at 8.64, indicating efficient cash utilization. The free cash flow to net income ratio is also strong at 5.97, underscoring effective cash flow management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.09B	860.80M	800.90M	717.80M	322.10M	478.20M
Gross Profit	509.90M	399.70M	356.40M	317.20M	81.10M	197.00M
EBITDA	203.30M	174.40M	149.00M	-90.80M	-19.20M	22.88M
Net Income	10.00M	-36.10M	-96.90M	-276.90M	-127.90M	-1.04M
Balance Sheet
Total Assets	2.74B	2.64B	2.72B	2.74B	3.12B	751.32M
Cash, Cash Equivalents and Short-Term Investments	262.60M	181.10M	134.10M	77.80M	88.90M	383.25K
Total Debt	420.60M	719.90M	721.00M	849.60M	860.60M	1.70B
Total Liabilities	1.22B	1.08B	1.17B	1.27B	1.33B	27.59M
Stockholders Equity	1.51B	1.51B	1.48B	1.40B	1.69B	652.05M
Cash Flow
Free Cash Flow	113.16M	50.30M	58.10M	5.20M	-16.70M	-20.85M
Operating Cash Flow	163.85M	99.10M	95.20M	39.40M	900.00K	-945.35K
Investing Cash Flow	-37.60M	-43.70M	-64.70M	-39.50M	-2.20B	-75.60M
Financing Cash Flow	39.40M	-3.30M	22.60M	-7.00M	1.54B	751.39M

Mirion Technologies Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 22.90
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MIR, the sentiment is Positive. The current price of 22.9 is above the 20-day moving average (MA) of 20.98, above the 50-day MA of 21.15, and above the 200-day MA of 17.73, indicating a bullish trend. The MACD of 0.19 indicates Negative momentum. The RSI at 62.42 is Neutral, neither overbought nor oversold. The STOCH value of 83.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MIR.

Mirion Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FELE	81 Outperform	$4.34B	25.24	14.38%	1.07%	2.20%	-3.74%
MWA	77 Outperform	$4.19B	28.28	17.33%	1.00%	10.19%	20.71%
NPO	71 Outperform	$4.62B	54.92	5.78%	0.56%	4.99%	169.24%
CXT	69 Neutral	$3.51B	23.37	13.98%	1.09%	10.28%	-16.81%
KAI	69 Neutral	$3.85B	36.41	12.21%	0.40%	1.74%	-7.64%
MIR	65 Neutral	$5.36B	562.65	0.67%	―	7.88%	―
Sector *	64 Neutral	$10.75B	15.58	7.62%	2.01%	2.80%	-14.32%

Mirion Technologies Corporate Events

Mirion Technologies Secures New $450 Million Loan Tranche

On June 5, 2025, Mirion Technologies entered into Amendment No. 5 to its Credit Agreement, introducing a new $450 million tranche of term loans maturing in 2032. This amendment allows for refinancing of existing loans and offers favorable terms such as reduced interest rates contingent on achieving certain credit ratings, alongside increased flexibility for financial operations, potentially enhancing the company’s financial stability and operational capacity.

Mirion Technologies Initiates $450M Refinancing Process

On May 29, 2025, Mirion Technologies initiated a refinancing process involving a $450 million tranche of replacement term loans. These loans are expected to mature in 2032 and will be used to refinance existing term loans under a previous credit agreement. The refinancing is anticipated to close in the second quarter of 2025, although its completion is subject to certain conditions.